de Craecker Francoise has filed 4 insider transactions across 1 company since June 2023.
Most recent transaction: a grant/award of 110000 shares of X4 Pharmaceuticals, Inc ($XFOR) on January 01, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 1, 2026 | X4 Pharmaceuticals, Inc | $XFOR | de Craecker Francoise | Director | A | Stock Option (right to buy) | 110000 | $0.00 | 0.0000 | 43,272,773 | 0.00% | 0.25% |
| June 9, 2025 | X4 Pharmaceuticals, Inc | $XFOR | de Craecker Francoise | Director | A | Common Stock | 1500 | $0.00 | 4,722.0000 | 201,062,211 | 46.55% | 0.00% |
| June 10, 2024 | X4 Pharmaceuticals, Inc | $XFOR | de Craecker Francoise | Director | A | Common Stock | 45000 | $0.00 | 96,667.0000 | 177,812,480 | 87.10% | 0.03% |
| June 13, 2023 | X4 Pharmaceuticals, Inc | $XFOR | de Craecker Francoise | Director | A | Common Stock | 45000 | $0.00 | 51,667.0000 | 63,525,845 | 674.97% | 0.07% |